Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Monkeypox Outbreak in Peru: Reflections after the COVID-19 Pandemic

Version 1 : Received: 7 May 2023 / Approved: 9 May 2023 / Online: 9 May 2023 (04:11:23 CEST)

A peer-reviewed article of this Preprint also exists.

Ramírez-Soto, M.C. Monkeypox Outbreak in Peru. Medicina 2023, 59, 1096. Ramírez-Soto, M.C. Monkeypox Outbreak in Peru. Medicina 2023, 59, 1096.

Abstract

Monkeypox is a zoonotic illness caused by the Orthopoxvirus monkeypox virus (MPXV). Since 1970, outbreaks of MPXV have occurred in several Sub-Saharan African countries. However, from May 2022 to April 2023, recent outbreaks of MPXV occurred in several countries outside of Africa, and these cases quickly spread to over 100 non-endemic countries on all continents. Because of this, in July 2022, World Health Organization declared monkeypox a Public Health Emergency of International. MPXV disproportionately affects men who have sex with men and members of the HIV-infected population. The current strategy for control and pre-exposure prophylaxis or post-exposure prophylaxis for people at high risk is vaccination. In this context, Peru has the fourth-highest number of MPXV cases in Latin America. Because of this, in this review, we describe public health indicators in Peru and reflect on the COVID-19 pandemic so that health authorities can join forces to identify and control MPXV transmission routes.

Keywords

Monkeypox outbreak; Public health; emergency; Peru

Subject

Medicine and Pharmacology, Epidemiology and Infectious Diseases

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.